Arcturus Therapeutics Partners With Thermo Fisher for ARCT-032
SAN DIEGO, Calif., July 2, 2026 Arcturus Therapeutics Holdings Inc. announced a strategic collaboration with Thermo Fisher Scientific to...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SAN DIEGO, Calif., July 2, 2026 Arcturus Therapeutics Holdings Inc. announced a strategic collaboration with Thermo Fisher Scientific to...
SEATTLE, June 30, 2026 AGC Biologics has announced a strategic partnership with Pyramid Pharma Services to expand its U.S.-based...
RANCHO CORDOVA, Calif., June 23, 2026 SK pharmteco has introduced SKyvecâ„¢, a next-generation multimodal viral vector platform designed to...
INCHEON, South Korea and SAN DIEGO, June 21, 2026 LOTTE Biologics has announced the successful completion of major construction...
GALWAY, Ireland, June 3, 2026 Medtronic has announced a series of major regulatory and clinical milestones aimed at significantly...
WALNUT CREEK, California, USA & SUZHOU, China | June 3, 2026 Dark Horse Consulting Group (DHCG) and Altruist Biologics...
SUZHOU, China, May 26, 2026 WuXi Vaccines, a wholly owned subsidiary of WuXi Biologics specializing in vaccine Contract Development...
HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 — AGC Biologics...
HUNTSVILLE, Ala. and KASSEL, Germany, May 20, 2026 Discovery Life Sciences has launched Luminos® Comprehensive, a next-generation IVDR-compliant clinical...
JERUSALEM, Israel, May 20, 2026 Scinai Immunotherapeutics Ltd. has announced the appointment of Eilon Elmalem as the new Site...
